Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostate Cancer Patients × repaglinide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

TP53 Y220C Mutation 1 Prostate Cancer Patients 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Healthy Adult Participants 1 Gastrointestinal Stromal Tumors 1 Diabetes Mellitus, Type 2 1 Advanced Solid Tumor 1 Advanced Malignancies 1

Interventions

repaglinide 1 carbon-11 acetate 1 Interviews as Topic 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04664725 2020-12-11

Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Unknown

Prostate Cancer Patients

Data powered by HemOnc (CC BY 4.0) Colophon ⚡